MYCOBUTIN Pharmacia (Mycobutin 150 mg)
Generic Name: rifabutin
Pill imprint MYCOBUTIN Pharmacia has been identified as Mycobutin 150 mg.
Mycobutin is used in the treatment of mycobacterium avium-intracellulare, treatment; mycobacterium avium-intracellulare, prophylaxis; tuberculosis, prophylaxis; tuberculosis, hiv positive and belongs to the drug class rifamycin derivatives. There is no proven risk in humans during pregnancy. Mycobutin 150 mg is not a controlled substance under the Controlled Substance Act (CSA).
- Generic Name:
- rifabutin
- Imprint:
- MYCOBUTIN Pharmacia
- Strength:
- 150 mg
- Color:
- Brown
- Size:
- 21.00 mm
- Shape:
- Capsule-shape
- Availability:
- Prescription only
- Drug Class:
- Rifamycin derivatives
- Pregnancy Category:
- B - No proven risk in humans
- CSA Schedule:
- Not a controlled drug
- Manufacturer:
- Pharmacia Corp
- National Drug Code (NDC):
- 00013-5301
- Inactive Ingredients:
- microcrystalline cellulose
magnesium stearate
ferric oxide red
silicon dioxide
sodium lauryl sulfate
titanium dioxide
More about Mycobutin (rifabutin)
Consumer resources
Professional resources
Related treatment guides
Disclaimer:
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.
